Gabon Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Funding
• Clinical Trials

Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge
Conditions:   Plasmodium Falciparum Malaria;   MalariaInterventions:   Biological: PfSPZ Challenge;   Drug: clindamycinSponsors:   Sanaria Inc.;   Centre de Recherches Médicales de Lambaréné, Gabon;   Institute of Tropical Medicine, University of TuebingenRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2014 Category: Research Source Type: clinical trials

Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge
Conditions:   Plasmodium Falciparum Malaria;   MalariaIntervention:   Biological: PfSPZ ChallengeSponsors:   Sanaria Inc.;   Centre de Recherches Médicales de Lambaréné, Gabon;   Institute of Tropical Medicine, University of TuebingenCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2014 Category: Research Source Type: clinical trials

Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge
Conditions:   Plasmodium Falciparum Malaria;   MalariaInterventions:   Biological: PfSPZ Challenge;   Drug: clindamycinSponsors:   Sanaria Inc.;   Centre de Recherches Médicales de Lambaréné, Gabon;   Institute of Tropical Medicine, University of TuebingenRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2014 Category: Research Source Type: clinical trials

Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults
Conditions:   Hookworm Infection;   Hookworm DiseaseInterventions:   Biological: Na-APR-1 (M74)/Alhydrogel®;   Biological: Na-GST-1/Alhydrogel®;   Biological: Hepatitis B vaccineSponsor:   Albert B. Sabin Vaccine InstituteRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2014 Category: Research Source Type: clinical trials